TWO SIGMA ADVISERS, LP - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 71 filers reported holding REVANCE THERAPEUTICS INC in Q1 2015. The put-call ratio across all filers is 1.63 and the average weighting 1.7%.

Quarter-by-quarter ownership
TWO SIGMA ADVISERS, LP ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$28,448,440
-43.0%
1,124,000
-27.5%
0.07%
-44.2%
Q1 2023$49,909,395
+131.9%
1,549,500
+32.9%
0.13%
+115.0%
Q4 2022$21,518,822
+57.0%
1,165,700
+129.7%
0.06%
+50.0%
Q3 2022$13,703,000
+814.8%
507,500
+368.2%
0.04%
+900.0%
Q2 2022$1,498,000
-7.8%
108,400
+67.8%
0.00%
-20.0%
Q3 2020$1,624,000
+8.6%
64,600
+5.6%
0.01%
+25.0%
Q2 2020$1,495,000
+103.7%
61,200
+23.4%
0.00%
+33.3%
Q1 2020$734,000
+241.4%
49,600
+198.8%
0.00%
+200.0%
Q2 2019$215,000
-62.3%
16,600
-54.1%
0.00%0.0%
Q1 2019$571,000
+21.0%
36,200
+90.5%
0.00%0.0%
Q3 2018$472,000
-58.4%
19,000
-54.0%
0.00%
-66.7%
Q2 2018$1,134,000
+65.1%
41,306
+85.2%
0.00%
+50.0%
Q1 2018$687,000
+100.3%
22,300
+132.3%
0.00%
+100.0%
Q4 2017$343,000
+9.6%
9,600
-2.0%
0.00%
-50.0%
Q2 2015$313,000
-43.0%
9,800
-63.0%
0.00%
-50.0%
Q1 2015$549,00026,5000.00%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q1 2015
NameSharesValueWeighting ↓
Palo Alto Investors LP 4,415,689$86,106,0006.66%
Evolutionary Tree Capital Management, LLC 176,336$3,439,0002.39%
Essex Woodlands Management, Inc. 457,085$8,913,0002.16%
HealthCor Management, L.P. 1,423,425$27,757,0001.85%
RICE HALL JAMES & ASSOCIATES, LLC 1,112,325$21,690,0000.86%
Waypoint Capital Advisors, LLC 53,989$1,016,0000.60%
Antara Capital LP 679,600$13,252,0000.40%
Rhenman & Partners Asset Management AB 198,358$3,868,0000.38%
Walleye Capital LLC 505,701$9,861,0000.26%
Polar Capital Holdings Plc 2,456,497$47,902,0000.22%
View complete list of REVANCE THERAPEUTICS INC shareholders